Short answer
Cigna (CI) filed an 8-K current report with the SEC on September 30, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure). 2026 outlook reaffirmed: adjusted revenue approximately $280B and adjusted EPS at least $30.45.
Cigna 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- 2026 outlook reaffirmed: adjusted revenue approximately $280B and adjusted EPS at least $30.45
- Evernorth adjusted operating income target at least $6.9B
- Cigna Healthcare adjusted operating income target at least $4.55B
- Cigna Healthcare medical care ratio outlook 83.7%-84.7%, signaling expected claims-cost discipline
- Long-term adjusted EPS growth target of 10%-14%, supporting the company’s capital-return and valuation narrative
Item EX-99.1 · Exhibit EX-99.1
- Reaffirms 2026 guidance: adjusted revenue ~$280B, adjusted EPS at least $30.45, medical care ratio 83.7%-84.7%
- Sets 2030 target of 10%-14% adjusted EPS CAGR and ~$50B cumulative operating cash flow
- Launches $3B multi-year modernization and productivity program, including AI-enabled workflows and supplier management
- Strategy centers on complex care across Cigna Healthcare and Evernorth, supporting growth in specialty services and pharmacy benefits
- New $10.5M, three-year foundation grant program addresses treatment access and non-clinical barriers for complex-care patients
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cigna 8-K filings
Get the next CI 8-K as it lands
Follow CI for push alerts, or ask the research agent what this filing means.